nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—MAPK3—periosteum—cleft lip	0.0763	0.284	CbGeAlD
Sulindac—MAPK3—mouth—cleft lip	0.0217	0.0807	CbGeAlD
Sulindac—AKR1B1—embryo—cleft lip	0.0213	0.0794	CbGeAlD
Sulindac—PTGS2—periosteum—cleft lip	0.0198	0.0737	CbGeAlD
Sulindac—AKR1B1—telencephalon—cleft lip	0.0174	0.0646	CbGeAlD
Sulindac—MAPK3—embryo—cleft lip	0.0155	0.0575	CbGeAlD
Sulindac—PTGS2—cartilage tissue—cleft lip	0.0139	0.0517	CbGeAlD
Sulindac—PPARD—telencephalon—cleft lip	0.0137	0.0508	CbGeAlD
Sulindac—MAPK3—telencephalon—cleft lip	0.0126	0.0468	CbGeAlD
Sulindac—AKR1B1—head—cleft lip	0.0108	0.0402	CbGeAlD
Sulindac—PPARD—head—cleft lip	0.0085	0.0316	CbGeAlD
Sulindac—MAPK3—head—cleft lip	0.00784	0.0291	CbGeAlD
Sulindac—CYP1A1—mouth—cleft lip	0.00672	0.025	CbGeAlD
Sulindac—PTGS2—mouth—cleft lip	0.00564	0.021	CbGeAlD
Sulindac—PTGS2—embryo—cleft lip	0.00402	0.0149	CbGeAlD
Sulindac—PTGS1—telencephalon—cleft lip	0.00342	0.0127	CbGeAlD
Sulindac—PTGS2—telencephalon—cleft lip	0.00327	0.0122	CbGeAlD
Sulindac—CYP1A1—head—cleft lip	0.00242	0.00901	CbGeAlD
Sulindac—PTGS1—head—cleft lip	0.00213	0.00792	CbGeAlD
Sulindac—PTGS2—head—cleft lip	0.00204	0.00757	CbGeAlD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—FGF2—cleft lip	0.0011	0.00151	CbGpPWpGaD
Sulindac—MAPK3—IL2-mediated signaling events—MYC—cleft lip	0.00108	0.00147	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—FGF2—cleft lip	0.00107	0.00147	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—FGF2—cleft lip	0.00107	0.00147	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—FGFR2—cleft lip	0.00107	0.00147	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—FGFR2—cleft lip	0.00107	0.00147	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—NODAL—cleft lip	0.00107	0.00146	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—NOS3—cleft lip	0.00106	0.00145	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—FGFR2—cleft lip	0.00106	0.00144	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—FGFR1—cleft lip	0.00105	0.00143	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—FGF10—cleft lip	0.00103	0.00141	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—FGFR2—cleft lip	0.00101	0.00138	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—FGFR2—cleft lip	0.001	0.00137	CbGpPWpGaD
Sulindac—PPARD—Metabolism—SLC19A1—cleft lip	0.001	0.00137	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—FGFR1—cleft lip	0.001	0.00137	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—FGFR1—cleft lip	0.001	0.00137	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—FGFR2—cleft lip	0.000998	0.00137	CbGpPWpGaD
Sulindac—PPARD—Ectoderm Differentiation—MYC—cleft lip	0.000994	0.00136	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—FGFR2—cleft lip	0.000994	0.00136	CbGpPWpGaD
Sulindac—CYP1A2—Phase II conjugation—MTR—cleft lip	0.000989	0.00135	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—FGFR3—cleft lip	0.000988	0.00135	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—FGFR1—cleft lip	0.000984	0.00135	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—TYMS—cleft lip	0.000975	0.00133	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000969	0.00133	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGF3—cleft lip	0.000965	0.00132	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGF7—cleft lip	0.000961	0.00131	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—SPRY2—cleft lip	0.000961	0.00131	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ARHGAP29—cleft lip	0.000958	0.00131	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—MTHFR—cleft lip	0.000953	0.0013	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—FGFR3—cleft lip	0.000945	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—FGFR3—cleft lip	0.000945	0.00129	CbGpPWpGaD
Sulindac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cleft lip	0.000944	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGF9—cleft lip	0.000941	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—FGFR1—cleft lip	0.00094	0.00129	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—NOS3—cleft lip	0.000939	0.00128	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—MTHFR—cleft lip	0.000936	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—FGFR1—cleft lip	0.000935	0.00128	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—FGFR2—cleft lip	0.000935	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—FGFR2—cleft lip	0.000935	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—FGFR2—cleft lip	0.000935	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—FGFR1—cleft lip	0.000931	0.00127	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—FGFR3—cleft lip	0.00093	0.00127	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—FGFR2—cleft lip	0.000926	0.00127	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—FGFR1—cleft lip	0.000926	0.00127	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—FGFR2—cleft lip	0.000918	0.00126	CbGpPWpGaD
Sulindac—MAPK3—TSH signaling pathway—MYC—cleft lip	0.000916	0.00125	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—FGFR2—cleft lip	0.000914	0.00125	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—FGFR1—cleft lip	0.000908	0.00124	CbGpPWpGaD
Sulindac—CYP1A1—Biological oxidations—MTR—cleft lip	0.000907	0.00124	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—MYC—cleft lip	0.000905	0.00124	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—MYC—cleft lip	0.000894	0.00122	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—FGF2—cleft lip	0.000892	0.00122	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—WNT9B—cleft lip	0.000889	0.00122	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—FGFR3—cleft lip	0.000888	0.00122	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGF8—cleft lip	0.000887	0.00121	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—NOS3—cleft lip	0.000886	0.00121	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—FGFR3—cleft lip	0.000884	0.00121	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—FGFR3—cleft lip	0.00088	0.0012	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—FGFR3—cleft lip	0.000875	0.0012	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—FGFR1—cleft lip	0.000871	0.00119	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—FGFR1—cleft lip	0.000871	0.00119	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—FGFR1—cleft lip	0.000871	0.00119	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—FGFR1—cleft lip	0.000863	0.00118	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—FGFR1—cleft lip	0.000856	0.00117	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—FGFR1—cleft lip	0.000852	0.00117	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—MTHFR—cleft lip	0.000851	0.00116	CbGpPWpGaD
Sulindac—PPARD—Metabolism—TCN2—cleft lip	0.000831	0.00114	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—FGFR2—cleft lip	0.000828	0.00113	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—FGFR3—cleft lip	0.000823	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—FGFR3—cleft lip	0.000823	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—FGFR3—cleft lip	0.000823	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.00082	0.00112	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—FGFR3—cleft lip	0.000816	0.00112	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—FGFR3—cleft lip	0.000809	0.00111	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—FGFR3—cleft lip	0.000805	0.0011	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—PTCH1—cleft lip	0.000796	0.00109	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGF10—cleft lip	0.000793	0.00109	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.000772	0.00106	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—FGF2—cleft lip	0.000763	0.00104	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—MTHFR—cleft lip	0.000757	0.00104	CbGpPWpGaD
Sulindac—MAPK3—Disease—WNT9B—cleft lip	0.00075	0.00103	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGF7—cleft lip	0.000733	0.001	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—FGF2—cleft lip	0.00073	0.000999	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—FGF2—cleft lip	0.00073	0.000999	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.000729	0.000998	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.000727	0.000994	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGF3—cleft lip	0.000722	0.000988	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—FGF2—cleft lip	0.000719	0.000983	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—WNT3—cleft lip	0.000706	0.000966	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGF9—cleft lip	0.000704	0.000963	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—FGF2—cleft lip	0.000686	0.000939	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—FGF2—cleft lip	0.000683	0.000934	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IRF6—cleft lip	0.000681	0.000931	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—FGF2—cleft lip	0.00068	0.00093	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—FGF2—cleft lip	0.000676	0.000925	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGF8—cleft lip	0.000676	0.000925	CbGpPWpGaD
Sulindac—MAPK3—Disease—ABCA4—cleft lip	0.000668	0.000914	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.000645	0.000883	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGFR2—cleft lip	0.000637	0.000871	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—FGF2—cleft lip	0.000636	0.00087	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—FGF2—cleft lip	0.000636	0.00087	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.000636	0.00087	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—FGF2—cleft lip	0.000631	0.000863	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—FGF2—cleft lip	0.000625	0.000855	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB3—cleft lip	0.000625	0.000854	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—FGF2—cleft lip	0.000622	0.000851	CbGpPWpGaD
Sulindac—MAPK3—Disease—SLC19A1—cleft lip	0.000611	0.000836	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000599	0.000819	CbGpPWpGaD
Sulindac—MAPK3—Disease—WNT3—cleft lip	0.000596	0.000815	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGF10—cleft lip	0.000594	0.000812	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—NOS3—cleft lip	0.000594	0.000812	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGFR1—cleft lip	0.000593	0.000812	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—MTR—cleft lip	0.000579	0.000792	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000576	0.000788	CbGpPWpGaD
Sulindac—PPARD—Metabolism—MTR—cleft lip	0.000576	0.000788	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—MYC—cleft lip	0.000575	0.000787	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000575	0.000787	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.000564	0.000771	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGFR3—cleft lip	0.000561	0.000767	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGF3—cleft lip	0.00055	0.000753	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—MYC—cleft lip	0.000549	0.000752	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—FGFR1—cleft lip	0.000537	0.000735	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGF9—cleft lip	0.000537	0.000734	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—WNT9B—cleft lip	0.000525	0.000718	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—FGF10—cleft lip	0.000512	0.000701	CbGpPWpGaD
Sulindac—MAPK3—Disease—TCN2—cleft lip	0.000507	0.000693	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOG—cleft lip	0.000503	0.000689	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000488	0.000667	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGFR2—cleft lip	0.000477	0.000652	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—TYMS—cleft lip	0.000469	0.000642	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ABCA4—cleft lip	0.000468	0.00064	CbGpPWpGaD
Sulindac—MAPK3—Immune System—SUMO1—cleft lip	0.000466	0.000638	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGF10—cleft lip	0.000453	0.000619	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—MYC—cleft lip	0.000449	0.000614	CbGpPWpGaD
Sulindac—PTGS2—Disease—WNT9B—cleft lip	0.000446	0.00061	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGFR1—cleft lip	0.000444	0.000608	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—MYC—cleft lip	0.000434	0.000593	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGF2—cleft lip	0.000433	0.000593	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGF7—cleft lip	0.000427	0.000584	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGFR3—cleft lip	0.00042	0.000574	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TYMS—cleft lip	0.000419	0.000574	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—WNT3—cleft lip	0.000417	0.000571	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.000411	0.000563	CbGpPWpGaD
Sulindac—PTGS2—Disease—ABCA4—cleft lip	0.000397	0.000544	CbGpPWpGaD
Sulindac—MAPK3—Disease—SPRY2—cleft lip	0.000394	0.000539	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGF7—cleft lip	0.000394	0.000539	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGF8—cleft lip	0.000394	0.000539	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000391	0.000535	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PTCH1—cleft lip	0.000387	0.000529	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SLC19A1—cleft lip	0.000384	0.000525	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—FGFR1—cleft lip	0.000383	0.000524	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—MYC—cleft lip	0.000381	0.000521	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC19A1—cleft lip	0.000364	0.000497	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGF8—cleft lip	0.000364	0.000497	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGFR2—cleft lip	0.000363	0.000497	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000356	0.000487	CbGpPWpGaD
Sulindac—PTGS2—Disease—WNT3—cleft lip	0.000354	0.000485	CbGpPWpGaD
Sulindac—PPARD—Metabolism—TYMS—cleft lip	0.000353	0.000483	CbGpPWpGaD
Sulindac—MAPK3—Disease—MTR—cleft lip	0.000351	0.00048	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—MYC—cleft lip	0.000342	0.000468	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGFR1—cleft lip	0.000339	0.000463	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGF2—cleft lip	0.000324	0.000444	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGF3—cleft lip	0.000321	0.000438	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NOS3—cleft lip	0.00032	0.000438	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGFR3—cleft lip	0.00032	0.000438	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—TCN2—cleft lip	0.000318	0.000435	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGF9—cleft lip	0.000313	0.000427	CbGpPWpGaD
Sulindac—PPARD—Metabolism—MTHFR—cleft lip	0.000308	0.000422	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SLC19A1—cleft lip	0.000304	0.000416	CbGpPWpGaD
Sulindac—PTGS2—Disease—TCN2—cleft lip	0.000301	0.000412	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGF3—cleft lip	0.000296	0.000405	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGF9—cleft lip	0.000289	0.000395	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—FGF2—cleft lip	0.00028	0.000383	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SPRY2—cleft lip	0.000276	0.000377	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF7—cleft lip	0.000276	0.000377	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NOS3—cleft lip	0.000271	0.00037	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC19A1—cleft lip	0.00027	0.00037	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGF10—cleft lip	0.000264	0.000361	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF8—cleft lip	0.000255	0.000348	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—TCN2—cleft lip	0.000252	0.000345	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGF2—cleft lip	0.000247	0.000338	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC19A1—cleft lip	0.000246	0.000337	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGF10—cleft lip	0.000243	0.000333	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF7—cleft lip	0.000234	0.00032	CbGpPWpGaD
Sulindac—PTGS2—Disease—SPRY2—cleft lip	0.000234	0.00032	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000233	0.000318	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PTCH1—cleft lip	0.000229	0.000313	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TCN2—cleft lip	0.000224	0.000306	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTR—cleft lip	0.00022	0.000301	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF8—cleft lip	0.000216	0.000296	CbGpPWpGaD
Sulindac—PPARD—Metabolism—NOS3—cleft lip	0.000215	0.000294	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MYC—cleft lip	0.000212	0.00029	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGFR2—cleft lip	0.000212	0.000289	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTR—cleft lip	0.000209	0.000286	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF3—cleft lip	0.000207	0.000283	CbGpPWpGaD
Sulindac—ALB—Metabolism—TCN2—cleft lip	0.000204	0.000279	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF9—cleft lip	0.000202	0.000276	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGFR1—cleft lip	0.000197	0.00027	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGFR2—cleft lip	0.000195	0.000267	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—MYC—cleft lip	0.000189	0.000259	CbGpPWpGaD
Sulindac—MAPK3—Disease—MTHFR—cleft lip	0.000188	0.000257	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGFR3—cleft lip	0.000186	0.000255	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—MYC—cleft lip	0.000183	0.000251	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGFR1—cleft lip	0.000182	0.000249	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF3—cleft lip	0.000176	0.000241	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTR—cleft lip	0.000175	0.000239	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC19A1—cleft lip	0.000172	0.000236	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGFR3—cleft lip	0.000172	0.000235	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF9—cleft lip	0.000172	0.000235	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF10—cleft lip	0.00017	0.000233	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—MYC—cleft lip	0.000169	0.000232	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTR—cleft lip	0.000155	0.000212	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF10—cleft lip	0.000145	0.000198	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGF2—cleft lip	0.000144	0.000197	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TCN2—cleft lip	0.000143	0.000195	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTR—cleft lip	0.000141	0.000194	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGFR2—cleft lip	0.000137	0.000187	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—TYMS—cleft lip	0.000135	0.000185	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGF2—cleft lip	0.000133	0.000182	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS3—cleft lip	0.000131	0.000179	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—cleft lip	0.00013	0.000178	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGFR1—cleft lip	0.000127	0.000174	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGFR3—cleft lip	0.00012	0.000165	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTHFR—cleft lip	0.000118	0.000161	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGFR2—cleft lip	0.000116	0.000159	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—cleft lip	0.000112	0.000153	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGFR1—cleft lip	0.000108	0.000148	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—TYMS—cleft lip	0.000107	0.000147	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGFR3—cleft lip	0.000102	0.00014	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTR—cleft lip	9.9e-05	0.000135	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TYMS—cleft lip	9.51e-05	0.00013	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—cleft lip	9.36e-05	0.000128	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—MYC—cleft lip	9.36e-05	0.000128	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF2—cleft lip	9.31e-05	0.000127	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—cleft lip	9.18e-05	0.000126	CbGpPWpGaD
Sulindac—MAPK3—Disease—MYC—cleft lip	8.69e-05	0.000119	CbGpPWpGaD
Sulindac—ALB—Metabolism—TYMS—cleft lip	8.67e-05	0.000119	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—cleft lip	8.31e-05	0.000114	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—cleft lip	8.23e-05	0.000113	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF2—cleft lip	7.91e-05	0.000108	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—cleft lip	7.8e-05	0.000107	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—cleft lip	7.58e-05	0.000104	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—cleft lip	6.53e-05	8.93e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MYC—cleft lip	6.09e-05	8.33e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TYMS—cleft lip	6.07e-05	8.3e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—cleft lip	5.8e-05	7.93e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—cleft lip	5.3e-05	7.25e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—cleft lip	5.28e-05	7.23e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MYC—cleft lip	5.17e-05	7.07e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—cleft lip	3.7e-05	5.05e-05	CbGpPWpGaD
